A novel synthetic opioid, cychlorphine, significantly more potent than fentanyl, has emerged as a major health threat in the United States. It has been linked to a number of recent fatal overdoses.
Concerning Statistics
Tennessee was one of the first states impacted, with the state’s health department reporting over 30 fatal overdoses linked to cychlorphine since October 2025. A subsequent notice from the White House’s Office of National Drug Control Policy explained the gravity of the situation, citing at least 41 deaths in Tennessee between July 2025 and February 2026, alongside at least 55 deaths nationwide.
Similar incidents have been recorded in Illinois, California, and Oklahoma, as per public health and law enforcement records.
Understanding the Danger
Cychlorphine’s extreme potency poses a significant risk. Even a minute amount can result in respiratory failure, according to Los Angeles County Department of Public Health. Dr. Nicholas Kardaras, CEO and chief clinical officer of the New York Center for Living, describes cychlorphine as “the new fentanyl on steroids.” He states it is one of the most potent synthetic opioids recently found in the illicit drug market.
The Drug Enforcement Administration (DEA) explains that cychlorphine operates in a manner similar to fentanyl, activating the same opioid receptors. However, cychlorphine’s effects can include severe sedation, slowed or halted breathing, or even death.
A Growing Threat
The drug is not approved for any medical use and frequently appears in counterfeit pills and other illegal substances. It is available in different forms, including pill, powder, and injectable liquid. This versatility in consumption methods contributes to its threat in the drug market.
Kardaras highlights the danger for younger individuals who are often more likely to experiment with drugs or inadvertently purchase counterfeit pills containing cychlorphine.
Naloxone as an Antidote
Naloxone, known by the brand name Narcan, can counteract cychlorphine’s opioid effects. However, reversing an overdose may require several doses due to the drug’s potency.
The DEA recommends immediate naloxone administration and calling 911 in suspected overdose cases.
Challenges in Detection
Standard fentanyl test strips and typical hospital opioid urine screenings fail to detect cychlorphine, exacerbating the issue. Kardaras notes that current drug tests are not designed to identify cychlorphine’s specific chemical structure.
In summary, cychlorphine presents a formidable threat due to its potency, undetectability in common drug tests, and potential need for multiple doses of naloxone for overdose reversal.
Leave a Reply